224 related articles for article (PubMed ID: 18582625)
1. Interpretation of associations in pharmacoepidemiology.
Kaufman DW
Semin Hematol; 2008 Jul; 45(3):181-8. PubMed ID: 18582625
[TBL] [Abstract][Full Text] [Related]
2. Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making.
Etminan M; Gill S; Fitzgerald M; Samii A
J Clin Pharmacol; 2006 Jan; 46(1):6-9. PubMed ID: 16397278
[TBL] [Abstract][Full Text] [Related]
3. Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice.
Weldeselassie YG; Whitaker HJ; Farrington CP
Epidemiol Infect; 2011 Dec; 139(12):1805-17. PubMed ID: 21849099
[TBL] [Abstract][Full Text] [Related]
4. Approaches to combat with confounding by indication in observational studies of intended drug effects.
McMahon AD
Pharmacoepidemiol Drug Saf; 2003; 12(7):551-8. PubMed ID: 14558178
[TBL] [Abstract][Full Text] [Related]
5. Using secondary data sources for pharmacoepidemiology and outcomes research.
Harpe SE
Pharmacotherapy; 2009 Feb; 29(2):138-53. PubMed ID: 19170584
[TBL] [Abstract][Full Text] [Related]
6. Assessing the validity of clinical trials.
Akobeng AK
J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):277-82. PubMed ID: 18728521
[TBL] [Abstract][Full Text] [Related]
7. Primer: administrative health databases in observational studies of drug effects--advantages and disadvantages.
Suissa S; Garbe E
Nat Clin Pract Rheumatol; 2007 Dec; 3(12):725-32. PubMed ID: 18037932
[TBL] [Abstract][Full Text] [Related]
8. Exposure misclassification as a result of free sample drug utilization in automated claims databases and its effect on a pharmacoepidemiology study of selective COX-2 inhibitors.
Jacobus S; Schneeweiss S; Chan KA
Pharmacoepidemiol Drug Saf; 2004 Oct; 13(10):695-702. PubMed ID: 15386727
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
Manchikanti L; Datta S; Smith HS; Hirsch JA
Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
[TBL] [Abstract][Full Text] [Related]
10. Data validity issues in using claims data.
Strom BL
Pharmacoepidemiol Drug Saf; 2001; 10(5):389-92. PubMed ID: 11802582
[TBL] [Abstract][Full Text] [Related]
11. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
12. Pharmacoepidemiology and gastroenterology: a close couple.
Leufkens HG
Scand J Gastroenterol Suppl; 2000; (232):105-8. PubMed ID: 11232486
[TBL] [Abstract][Full Text] [Related]
13. Immortal time bias in pharmaco-epidemiology.
Suissa S
Am J Epidemiol; 2008 Feb; 167(4):492-9. PubMed ID: 18056625
[TBL] [Abstract][Full Text] [Related]
14. From randomized controlled trials to observational studies.
Silverman SL
Am J Med; 2009 Feb; 122(2):114-20. PubMed ID: 19185083
[TBL] [Abstract][Full Text] [Related]
15. Efficient sampling approaches to address confounding in database studies.
Hanley JA; Dendukuri N
Stat Methods Med Res; 2009 Feb; 18(1):81-105. PubMed ID: 18815164
[TBL] [Abstract][Full Text] [Related]
16. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
[TBL] [Abstract][Full Text] [Related]
17. The case-crossover study design in pharmacoepidemiology.
Delaney JA; Suissa S
Stat Methods Med Res; 2009 Feb; 18(1):53-65. PubMed ID: 18765504
[TBL] [Abstract][Full Text] [Related]
18. A multiattribute model for evaluating the benefit-risk profiles of treatment alternatives.
Felli JC; Noel RA; Cavazzoni PA
Med Decis Making; 2009; 29(1):104-15. PubMed ID: 18812582
[TBL] [Abstract][Full Text] [Related]
19. Expanding the evidence base in transplantation: the complementary roles of randomized controlled trials and outcomes research.
Takemoto SK; Arns W; Bunnapradist S; Garrison LP; Guirado L; Kalo Z; Oniscu G; Opelz G; Scolari MP; Stefoni S; Yaqoob M; Brennan DC
Transplantation; 2008 Jul; 86(1):18-25. PubMed ID: 18622271
[TBL] [Abstract][Full Text] [Related]
20. A systematic review on the application of pharmacoepidemiology in assessing prescription drug-related adverse events in pediatrics.
Luo X; Cappelleri JC; Frush K
Curr Med Res Opin; 2007 May; 23(5):1015-24. PubMed ID: 17526119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
